Patents by Inventor Andrew T. Vo

Andrew T. Vo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED METHODS
    Publication number: 20220305061
    Abstract: A method for making an acellular human amnion-derived composition configured for therapeutic use is disclosed and generally includes the steps: obtaining amniotic membrane tissue; testing the amniotic membrane tissue for pathogens; washing the amniotic membrane tissue; manually removing blood-containing chorion tissue from the amniotic membrane tissue decellularizing the amniotic membrane tissue with xeno-free enzymes; collecting amniotic cells from the decellularized amniotic membrane tissue; seeding the amniotic cells for culture into xeno-free media formulated for mesenchymal stem cells; growing the amniotic cells to a specified confluency; collecting conditioned media; and freezing the collected conditioned media; wherein the method further includes irradiating the conditioned media.
    Type: Application
    Filed: June 16, 2022
    Publication date: September 29, 2022
    Applicant: AXOLOTL BIOLOGIX, INC.
    Inventors: Robert S. Kellar, Robert B. Diller, Robert G. Audet, Eric T. Lee, Andrew T. Vo
  • COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED METHODS
    Publication number: 20220152119
    Abstract: A method for making an acellular human amnion-derived composition configured for therapeutic use is disclosed and generally includes the steps: obtaining amniotic membrane tissue; testing the amniotic membrane tissue for pathogens; washing the amniotic membrane tissue; manually removing blood-containing chorion tissue from the amniotic membrane tissue decellularizing the amniotic membrane tissue with xeno-free enzymes; collecting amniotic cells from the decellularized amniotic membrane tissue; seeding the amniotic cells for culture into xeno-free media formulated for mesenchymal stem cells; growing the amniotic cells to a specified confluency; collecting conditioned media; and freezing the collected conditioned media; wherein the method further includes irradiating the conditioned media.
    Type: Application
    Filed: August 10, 2020
    Publication date: May 19, 2022
    Applicant: AXOLOTL BIOLOGIX, INC.
    Inventors: Robert S. Kellar, Robert B. Diller, Robert G. Audet, Eric T. Lee, Andrew T. Vo